J. Jett

发表

Effectiveness of smoking cessation self-help materials in a lung cancer screening population.

S. Swensen, M. Clark, L. Cox, 2004, Lung cancer.

Screening for lung cancer with low-dose spiral computed tomography.

S. Swensen, J. Jett, T. Hartman, 2000, American journal of respiratory and critical care medicine.

Screening for lung cancer with low-dose spiral computed tomography.

S. Swensen, J. Jett, T. Hartman, 2000, American journal of respiratory and critical care medicine.

Lung cancer screening with CT: Mayo Clinic experience.

S. Swensen, J. Jett, T. Hartman, 2003, Radiology.

Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer

A. Stromberg, J. Jett, L. Zhong, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Benefits and harms of CT screening for lung cancer: a systematic review.

D. Berry, G. Colditz, C. Azzoli, 2012, JAMA.

Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

J. Austin, H. Macmahon, S. Swensen, 2005, Radiology.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

Masahiro Tsuboi, Iver Petersen, Hisao Asamura, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer

J. Jett, S. Mandrekar, N. Foster, 2011, Cancer.

Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

Rebecca M. Lindell, S. Swensen, J. Jett, 2007, Radiology.

In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin

J. Jett, N. Saijo, W. Hong, 2004, Cancer Chemotherapy and Pharmacology.

Computed tomography screening and lung cancer outcomes.

Ugo Pastorino, Colin B Begg, Peter B Bach, 2007, JAMA.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

Charles A Powell, Elisabeth Brambilla, Kavita Garg, 2011, Proceedings of the American Thoracic Society.

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.

J. Jett, A. Brody, M. Friedman, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

J. Jett, D. Midthun, C. Powell, 2015, American journal of respiratory and critical care medicine.

Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Arnold J Stromberg, A. Stromberg, J. Jett, 2005, American journal of respiratory and critical care medicine.

Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

Sumithra J. Mandrekar, J. Jett, S. Mandrekar, 2007, Clinical Cancer Research.

18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma *

J. Jett, M. Aubry, P. Peller, 2009, Journal of medical imaging and radiation oncology.

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

J. Jett, C. Harris, P. Pairolero, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool

J. Jett, D. Ahlquist, E. Edell, 2000 .

A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).

J. Jett, J. Sloan, S. Hillman, 2002, International journal of radiation oncology, biology, physics.

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

J. Jett, W. Travis, P. Pairolero, 1995, Carcinogenesis.

Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic

J. Jett, A. Majid, F. Kheir, 2020, Chest.

Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma.

J. Jett, J. Pujol, J. Su, 1993, Journal of the National Cancer Institute.

Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.

J. Jett, J. Krook, John Q. Su, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cannabis Use, Lung Cancer, and Related Issues

J. Jett, G. Warren, E. Stone, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer

J. Jett, S. Mandrekar, A. Adjei, 2007, Cancer.

Chemotherapy for advanced lung cancer. When to expect a response.

J. Jett, D. Midthun, 1997, Postgraduate medicine.

Current treatment of unresectable lung cancer.

J. Jett, 1993, Mayo Clinic proceedings.

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007

J. Crowley, A. Nicholson, V. Rusch, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expert opinion: role of percutaneous biopsy of part-solid nodules in the IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma.

J. Jett, D. Naidich, P. Boiselle, 2011, Journal of thoracic imaging.

Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

E. Perez, J. Jett, S. Hillman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Screening for lung cancer in high-risk groups: current status of low-dose spiral CT scanning and sputum markers.

J. Jett, 2000, Seminars in respiratory and critical care medicine.

Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience.

A. Zinsmeister, J. Jett, P. Pairolero, 1986, Chest.

Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer.

R. Day, J. Jett, S. Ramalingam, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Small cell lung cancer: current therapy and promising new regimens.

J. Jett, S. Okuno, 2002, The oncologist.

Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.

J. Jett, Lisa Brown, E. David, 2018, The Annals of thoracic surgery.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Fergus Gleeson, Heber MacMahon, Jin Mo Goo, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Malignant pleural mesothelioma. A proposed new staging system.

J. Jett, 1995, Chest.

Malignant Pleural Mesothelioma

J. Jett, T. Peikert, 1995 .

Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis.

J. Jett, J. Sloan, P. Novotny, 2004, Mayo Clinic proceedings.

Superior sulcus tumors and Pancoast's syndrome.

J. Jett, 2003, Lung cancer.

Are Airflow Obstruction and Radiographic Emphysema Risk Factors for Lung Cancer

J. Jett, F. Maldonado, P. Decker, 2009, ATS 2009.

Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.

D. Aberle, J. Jett, C. Berg, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

CT screening for lung cancer: five-year prospective experience.

Anne-Marie Sykes, Sumithra J Mandrekar, S. Swensen, 2005, Radiology.

O-127 Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography

S. Swensen, J. Jett, T. Hartman, 2003 .

Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

L. Liotta, J. Herman, J. Jett, 2001, Cancer research.

Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.

J. Jett, H. Tazelaar, C. F. Thomas, 2001, Chest.

Superior pulmonary sulcus tumors and Pancoast's syndrome.

J. Jett, S. Arcasoy, 1997, The New England journal of medicine.

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

J. Austin, A. Nicholson, R. Rami-Porta, 2015 .

Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients.

S. Swensen, J. Jett, M. Aubry, 2007, Chest.

The Relationship Between Emphysema on CT Scan and Lung Cancer: Response

J. Jett, F. Maldonado, P. Decker, 2011 .

Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum.

J. Jett, D. Strollo, M. L. Rosado de Christenson, 1997, Chest.

State of the journal: 2011.

J. Jett, 2011, Journal of Thoracic Oncology.

Staging classification committee.

J. Jett, R. Ginsberg, R. Tsuchiya, 1997, Lung cancer.

Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive‐stage small cell lung cancer, N0423

J. Jett, N. Foster, K. Rowland, 2010, Cancer.

State of the Journal: 2010

J. Jett, 2010 .

State of the Journal.

J. Jett, D. Midthun, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

E05-02: IASLC Staging Project: T-desriptors

J. Crowley, R. Rami-Porta, M. Tsuboi, 2007 .

A front-line window of opportunity phase II study of sorafenib in patients with advanced non-small cell lung cancer: A North Central Cancer Treatment Group study

J. Jett, S. Mandrekar, S. Hillman, 2007 .

Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

E. Shaw, J. Jett, E. Creagan, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.

R. Day, J. Jett, J. Aisner, 1996, Seminars in oncology.

Clinical strategies for solitary pulmonary nodule.

S. Swensen, J. Jett, D. Midthun, 1992, Annual review of medicine.

Early detection of lung cancer: Today's approach

J. Jett, D. Midthun, 1998 .

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

J. Jett, J. Sloan, S. Hillman, 2003, Supportive Care in Cancer.

Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works

J. Jett, D. Midthun, 2011, Annals of Internal Medicine.

Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening

S. Swensen, M. Clark, J. Jett, 2005, Cancer.

S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC)

J. Crowley, J. Jett, H. Lenz, 2008 .

Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer

J. Jett, K. Kelly, D. Gandara, 2007 .

MTP11-01: Pulmonary toxicity of therapy

J. Jett, 2007 .

Thoracic surgical operations in patients enrolled in a computed tomographic screening trial.

S. Swensen, J. Jett, P. Pairolero, 2004, The Journal of thoracic and cardiovascular surgery.

Commentary: CT screening for lung cancer--caveat emptor.

J. Jett, D. Midthun, 2008, The oncologist.

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.

L. Liotta, J. Jett, C. Harris, 1998, Pharmacogenetics.

p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.

L. Liotta, J. Jett, A. Borkowski, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

J. Jett, M. Hammond, R. Livingston, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.

L. Liotta, J. Jett, C. Harris, 1998, Human pathology.

Principled Lung Cancer Screening Follows Screening Principles.

J. Jett, P. Mazzone, 2018, Chest.

Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.

Ping Yang, Jason A Wampfler, J. Jett, 2004, The Annals of thoracic surgery.

Computed tomography screening and lung cancer outcomes.

C. Begg, S. Swensen, J. Jett, 2007, Revista portuguesa de pneumologia.

Limitations of Screening for Lung Cancer with Low-Dose Spiral Computed Tomography

J. Jett, 2005, Clinical Cancer Research.

Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung.

E. Shaw, J. Jett, E. Creagan, 1989, International journal of radiation oncology, biology, physics.

Imatinib mesylate-induced interstitial pneumonitis.

J. Jett, T. Hobday, Cynthia X. Ma, 2003, Mayo Clinic proceedings.

A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma

J. Jett, H. Tazelaar, John Q. Su, 1992, Cancer.

Systemic treatment of advanced lung carcinoid tumors: show me the data!

J. Jett, L. Carr, 2013, Chest.

Approach to the solitary pulmonary nodule.

S. Swensen, J. Jett, D. Midthun, 1993, Mayo Clinic proceedings.

An integrated approach to evaluation of the solitary pulmonary nodule.

S. Swensen, J. Jett, P. Pairolero, 1990, Mayo Clinic proceedings.

5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size.

Rebecca M. Lindell, S. Swensen, J. Jett, 2009, Chest.

Phase II trial of topotecan for the treatment of mesothelioma.

J. Jett, R. Marks, S. Nair, 1998, American journal of clinical oncology.

Magnetic resonance imaging of the chest: a diagnostic comparison with computed tomography and hilar tomography.

J. Jett, P. E. Bernatz, L. Brown, 1984, Magnetic resonance imaging.

What's new in staging of lung cancer?

J. Jett, 1997, Chest.

Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report

D. Ettinger, J. Jett, P. Houtte, 1991 .

The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines

J. Jett, N. Saijo, W. Hong, 2004, Cancer Immunology and Immunotherapy.

Is there a role for interferon in the treatment of small cell lung cancer

J. Jett, 1989 .

Peripheral Blood Mononuclear Cells Aryl Hydrocarbon Hydroxylase Activity in Subpopulations of Updated

J. Jett, H. Moses, J. Stobo, 2006 .

Benzo(A)pyrene metabolism and blast transformation in peripheral blood mononuclear cells from smoking and nonsmoking populations and lung cancer patients

J. Jett, R. Fontana, W. Taylor, 1978, Cancer.

Aryl hydrocarbon hydroxylase activity in subpopulations of peripheral blood mononuclear cells.

J. Jett, H. Moses, J. Stobo, 1978, Cancer research.

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies

J. Jett, R. Marks, Shaji K. Kumar, 2013, Investigational New Drugs.

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.

J. Jett, J. Sloan, J. Knost, 2000, Lung cancer.

Alterations of p14 ARF , p53 , and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma

L. Liotta, J. Herman, J. Jett, 2001 .

Alterations of p 14 ARF , p 53 , and p 73 Genes Involved in the E 2 F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma

L. Liotta, J. Herman, J. Jett, 2001 .

Comprehensive Respiratory Medicine

J. Jett, R. Albert, S. Spiro, 1999 .

Preoperative evaluation of pulmonary risk factors

J. Jett, D. Mohr, 1988, Journal of General Internal Medicine.

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

J. Jett, R. Goldberg, C. Loprinzi, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I‐II Study of Sequential Infusion VP‐16 and Cisplatin Therapy in Advanced Lung Cancer

J. Jett, J. Krook, C. Little, 1989, American Journal of Clinical Oncology.

A phase I study of BAY 43-9006 and gefitinib in patients with refractory or recurrent non-small-cell lung cancer (NSCLC)

J. Jett, S. Mandrekar, R. Marks, 2005 .

Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.

V. Lowe, J. Jett, J. Mandrekar, 2008, Mayo Clinic proceedings.

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer: A North Central Cancer Treatment Group Study

E. Perez, J. Jett, S. Hillman, 2010, American journal of clinical oncology.

Pulmonary resection of metastatic renal cell carcinoma.

A. Zinsmeister, J. Jett, P. Pairolero, 1983, Chest.

Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.

J. Jett, R. Marks, J. Kugler, 1999, American journal of clinical oncology.

New agents in the treatment of small cell lung cancer.

J. Jett, M. Ghaemmaghami, 1998, Chest.

Phase II trial of edatrexate in small cell lung cancer

J. Jett, R. Morton, John Q. Su, 1994, Cancer.

Pemetrexed (Pem)/gemcitabine (Gem) as front-line therapy for advanced NSCLC: A randomized, phase II trial of three schedules.

J. Jett, S. Mandrekar, A. Adjei, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non‐small cell lung cancer. A trial of the north central cancer treatment group

J. Jett, J. Krook, R. Morton, 1993, Cancer.

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.

J. Jett, J. Sloan, R. Goldberg, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.

D. Schaid, E. Shaw, J. Jett, 1996, American journal of clinical oncology.

Measurable or assessable disease in lung cancer trials: does it matter?

J. Jett, R. Goldberg, J. Krook, 1994, Journal of Clinical Oncology.

Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease.

S. Swensen, J. Jett, J. Myers, 1999, The American journal of surgical pathology.

Glomus tumor of the trachea: value of multidetector computed tomographic virtual bronchoscopy.

J. Jett, G. Aughenbaugh, M. Allen, 2004, Mayo Clinic proceedings.

A new immunodeficiency disorder in humans involving NK cells

J. Roder, J. Jett, A. Fauci, 1980, Nature.

Plastic bronchitis: an old disease revisited.

J. Jett, H. Tazelaar, L. Keim, 1991, Mayo Clinic proceedings.

Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age): A Phase II North Central Cancer Treatment Group Study

E. Perez, J. Jett, S. Hillman, 2003, American journal of clinical oncology.

Considerations in optimizing radiation therapy for non-small cell lung cancer.

J. Jett, J. Greenberger, M. Epperly, 1998, Chest.

8:00-8:25 Presentation, Diagnosis, and Evaluation of Lung Cancer by Pulmonary Physicians

S. Swensen, C. Henschke, J. Jett, 2000 .

Alternating Chemotherapy With or Without VP‐16 in Extensive‐Stage Small‐Cell Lung Cancer

J. O'fallon, J. Jett, J. Laurie, 1989, American journal of clinical oncology.

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

J. Jett, S. Hillman, K. Rowland, 2006, Cancer investigation.

The value of bronchoscopy in the diagnosis of mycobacterial disease. A five-year experience.

J. Jett, D. Cortese, D. E. Dines, 1981, Chest.

A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group.

J. Jett, R. Marks, S. Jung, 1995, Seminars in oncology.

Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung.

E. Shaw, J. Jett, K. Rowland, 1993, Journal of the National Cancer Institute.

Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.

J. Jett, J. Sloan, R. Morton, 1999, American journal of clinical oncology.

AProspective Study ofPulmonary Function inPatients Receiving Mitomycin

J. Jett, H. Tazelaar, M. Veeder, 2015 .

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

J. Jett, A. Dowlati, S. Remick, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multi-Institutio nal P hase I /II T rial o f P aclitaxel, Cisplatin, a nd E toposide W ith C oncurrent R adiation f or Limited-Stage S mall-Cell L ung C arcinoma

J. Jett, A. Dowlati, S. Remick, 2000 .

Status of Journal of Thoracic Oncology in 2011

J. Jett, 2012 .

Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

S. Thibodeau, J. Jett, R. Marks, 2005, Chest.

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

E. Perez, J. Jett, S. Mandrekar, 2008, Lung cancer.

Acquired immunodeficiency syndrome associated with blood-product transfusions.

J. Jett, J. Katzmann, H. Homburger, 1983, Annals of internal medicine.

Inhibitory effect of murine recombinant interferon (beta) on the pulmonary metastasis of B-16 melanoma.

J. Jett, N. Saijo, Y. Sasaki, 1986, Japanese journal of cancer research : Gann.

Augmentation of human monocyte-mediated cytolysis by interferon.

J. Jett, A. Mantovani, R. Herberman, 1980, Cellular immunology.

Randomized phase II trial of sulindac for lung cancer chemoprevention.

S. Lam, J. Jett, M. Tockman, 2013, Lung cancer.

Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference.

J. Jett, M. Freedman, G. Strauss, 2005, Chest.

Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases

J. Jett, P. E. Bernatz, J. R. Muhm, 1986, Cancer.

Effect of various immunoregulatory substances on the growth inhibitory activity (GIA) of human monocytes against lymphoblastoid cell lines.

J. Jett, R. Connor, R. Herberman, 1982, Immunopharmacology.

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

E. Shaw, J. Jett, C. Loprinzi, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow cytometric enrichment for respiratory epithelial cells in sputum

Carissa A. Sanchez, J. Jett, B. Reid, 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Treatment of Small Cell Lung Cancer Diagnosis and Management of Lung Cancer , 3 rd ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

J. Jett, S. Schild, G. Kalemkerian, 2013 .

Molecular and Immune Biomarker Testing in Squamous‐Cell Lung Cancer: Effect of Current and Future Therapies and Technologies

Edward S. Kim, C. Obasaju, M. Socinski, 2018, Clinical lung cancer.

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Edward S. Kim, C. Obasaju, M. Socinski, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Scientific Advances in Thoracic Oncology 2016.

H. Groen, C. Rudin, R. Rami-Porta, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

J. Crowley, J. Jett, D. Gandara, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.

L. Liotta, J. Jett, A. Borkowski, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development.

Claude Deschamps, James Jett, J. Jett, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

J. Jett, F. Khuri, H. Choy, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules

J. Jett, P. Massion, D. Carbone, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer

A. Stromberg, J. Jett, N. H. Khattar, 2010, Cancer biology & therapy.

Clinical Respiratory Medicine

Stephen G. Spiro, J. Jett, R. Albert, 2004 .

Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation

E. Shaw, B. O'neill, J. Jett, 1989, American journal of clinical oncology.

Comparison of Programmed Death Ligand‐1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens

J. Jett, D. Midthun, M. Aubry, 2018, Chest.

Response to Letter to the Editor.

Edward S. Kim, J. Jett, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A prospective study of pulmonary function in patients receiving mitomycin.

J. Jett, H. Tazelaar, M. Veeder, 1996, Chest.

The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

J. Crowley, V. Rusch, R. Rami-Porta, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

J. Crowley, R. Rami-Porta, M. Tsuboi, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Five-Year Experience

Denis A. Cortese, J. Jett, D. Cortese, 2017 .

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion

J. Jett, M. Metintaş, H. Yıldırım, 2015, BioMed research international.

Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.

J. Jett, G. Aughenbaugh, M. Aubry, 2009, Clinical lung cancer.

Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers

J. Jett, F. Shepherd, H. Roberts, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification

J. Austin, A. Nicholson, I. Petersen, 2009 .

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

J. Crowley, J. Jett, K. Kelly, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.

J. Jett, J. Sloan, R. Marks, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I II C omparison o f T wice-Daily S plit-Course Irradiation V ersus O nce-Daily I rradiation f or P atients With L imited S tage S mall-Cell L ung C arcinoma

J. Jett, J. Sloan, R. Marks, 1999 .

Impact of Pretreatment Factors on Adverse Events: A Pooled Analysis of North Central Cancer Treatment Group Advanced Stage Non-small Cell Lung Cancer Trials

J. Jett, B. Bot, S. Mandrekar, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

C. Obasaju, J. Jett, S. Mandrekar, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines

J. Jett, K. Suemasu, N. Saijo, 2004, Investigational New Drugs.

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: A randomized, phase III trial

T. Therneau, J. Earle, J. Jett, 1991 .

Road ahead to respiratory health: Experts chart future research directions

D. Hansell, J. Jett, J. Stradling, 2009, Respirology.

Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.

D. Ettinger, J. Jett, J. Luketich, 1999, Clinical lung cancer.

A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

J. Jett, P. Novotny, J. Sloan, 2004, Supportive Care in Cancer.

A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.

T. Therneau, J. Jett, E. Creagan, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

53 – Clinical Aspects of Lung Cancer

J. Jett, N. Pastis, N. Tanner, 2016 .

Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.

E. Shaw, J. Jett, R. Eagan, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

J. Earle, J. Jett, J. Krook, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group.

T. Therneau, J. Jett, J. Krook, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations.

J. Jett, W. Pao, Y. Yatabe, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Targeted therapy for non-small cell lung cancer.

J. Jett, L. Carr, 2013, American journal of respiratory and critical care medicine.

Progress in the development of volatile exhaled breath signatures of lung cancer.

J. Jett, P. Mazzone, P. Rhodes, 2015, Annals of the American Thoracic Society.

Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis

J. Jett, F. Maldonado, 2010, Current opinion in pulmonary medicine.

Non-small-cell lung cancer

A. Nicholson, J. Jett, F. Shepherd, 2011, The Lancet.

Ccr Translations the Tissue Is the Issue: Personalized Medicine for Non-small Cell Lung Cancer Clinical Cancer Research

A. Nicholson, J. Jett, F. Shepherd, 2022 .

Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum.

J. Jett, D. Strollo, M. Rosado-de-Christenson, 1997, Chest.

Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).

J. Jett, S. Schild, K. Kesler, 2007, Chest.

Outcome in Patients Presenting With Regional Lymph Node Involvement

J. Jett, H. Tazelaar, J. Thomas, 2017 .

Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

J. Jett, S. Hillman, N. Foster, 2006, American journal of clinical oncology.

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.

J. Jett, G. Silvestri, R. Osarogiagbon, 2020, Chest.

The Value of Bronchoscopy in the Diagnosis CHEST , 80 : 5 , NOVEMBER , 1981 BRONCHOSCOPY IN DIAGNOSIS OF MYCOBACTERIAL DISEASE 575 of Mycobacterial Disease

J. Jett, D. Cortese, D. E. Dines, 2006 .

p53 mutations and occupational exposures in a surgical series of lung cancers.

L. Liotta, J. Jett, C. Harris, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.

L. Liotta, J. Jett, C. Harris, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Body plethysmography in the evaluation of intrathoracic airway abnormalities.

J. Jett, K. Beck, M. A. Reinoso, 1992, Chest.

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable

Edward S. Kim, J. Jett, G. Silvestri, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancer: the American view.

J. Jett, D. Sanderson, 1989, The European respiratory journal.

Prognostic factors differ by tumor stage for small cell lung cancer

J. Jett, S. Mandrekar, R. Marks, 2009, Cancer.

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.

J. Jett, S. Hillman, D. Northfelt, 2005, International journal of radiation oncology, biology, physics.

Long‐Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

J. Jett, S. Hillman, A. Tan, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Colony Inhibitory Effect of Recombinant Human Tumor Necrosis Factor (rH-TNF) and/or Recombinant Human Interferon (rH-IFN)-α -β and -γ on Human Lung Cancer Cell Lines

J. Jett, N. Saijo, W. Hong, 1987 .

Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines.

J. Jett, N. Saijo, W. Hong, 1987, Japanese journal of clinical oncology.

Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.

J. Jett, A. Levine, H. Levy, 1985, Journal of Biological Response Modifiers.

The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.

J. Jett, K. Eguchi, N. Saijo, 1986, Japanese journal of clinical oncology.

Stage-associated incidence of serum circulating immune complexes in patients with untreated bronchogenic carcinoma

J. Jett, R. E. Ritts, A. Ruiz-Argüelles, 1982, Cancer Immunology, Immunotherapy.

udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice

J. Jett, J. Robertson, L. Peek, 2014 .

A prognostic model for advanced stage nonsmall cell lung cancer

J. Jett, S. Mandrekar, S. Hillman, 2006, Cancer.

Computed tomographic screening for lung cancer: home run or foul ball?

S. Swensen, J. Jett, T. Hartman, 2003, Mayo Clinic proceedings.

Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.

T. Lesnick, J. Jett, J. Sloan, 2002, Lung cancer.

Do patients with schizophrenia receive state‐of‐the‐art lung cancer therapy? A brief report

J. Jett, R. Marks, G. Croghan, 2008, Psycho-oncology.

LUNG MASS AS A MANIFESTATION OF IGG4-RELATED LUNG DISEASE

J. Jett, H. Sekiguchi, P. Escalante, 2009 .

Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens.

Jesse S. Voss, J. Jett, M. Henry, 2010, American journal of respiratory and critical care medicine.

Aryl hydrocarbon hydroxylase in man and lung cancer.

J. Jett, R. Fontana, H. Moses, 1978, Human genetics. Supplement.

Variation of microsomal mixed function oxidase(s) and human lung cancer

J. Jett, R. Fontana, H. Moses, 1980, Cancer.

Computed Tomography Screening for Lung Cancer—Reply

C. Begg, S. Swensen, J. Jett, 2007 .

Phospho-Akt Overexpression in Non–Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage

J. Jett, A. Brody, M. Friedman, 2004, Clinical Cancer Research.

Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study

Zhifu Sun, Sumithra J Mandrekar, Ping Yang, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.

J. Jett, B. Bot, S. Mandrekar, 2007, International journal of radiation oncology, biology, physics.

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials

J. Jett, S. Mandrekar, J. Sloan, 2007, Cancer.

Update in lung cancer 2005.

Y. Miller, J. Jett, 2006, American journal of respiratory and critical care medicine.

Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer

J. Jett, P. Mazzone, P. Rhodes, 2015, BMC Cancer.

Update on screening for lung cancer.

J. Jett, D. Midthun, 2008, Seminars in Respiratory and Critical Care Medicine.

Screening for non-small cell lung cancer.

J. Jett, R. Ashton, 2005, Seminars in oncology.

Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer

J. Jett, P. Mazzone, P. Rhodes, 2015, BMC Cancer.

Screening for Lung Cancer

J. Jett, J. Ravenel, 2013 .

Does interstitial lung disease predispose to lung cancer?

J. Jett, C. Daniels, 2005, Current opinion in pulmonary medicine.

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.

R. Arusell, J. Jett, S. Hillman, 2004, International journal of radiation oncology, biology, physics.

Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis.

Fabien Maldonado, Brian J Bartholmai, S. Swensen, 2010, Chest.

Change in smoking status after spiral chest computed tomography scan screening

S. Swensen, J. Jett, C. Patten, 2003, Cancer.

Pathologic review of the Mayo Lung Project

E. Bergstralh, J. Jett, W. Travis, 2002, Cancer.

Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.

J. Jett, R. Marks, A. Adjei, 2005, Lung cancer.

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive‐stage small cell lung carcinoma

J. Jett, S. Hillman, R. Marks, 2003, Cancer.

Stage II (T3) lung cancer.

J. Jett, M. Allen, T. Kozelsky, 2001, Chest surgery clinics of North America.

Screening for lung cancer: no longer a taboo subject.

J. Jett, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study

J. Gurney, S. Swensen, J. Jett, 2002, European Respiratory Journal.

38 Topotecan and paclitaxel in extensive stage small cell lung cancer (ED-SCLC) patients without prior therapy

R. Day, J. Jett, M. Levitt, 1997 .

Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group

J. Jett, J. Krook, J. Kugler, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Guidelines on treatment of stage IIIB non-small cell lung cancer.

J. Jett, W. Sause, W. Scott, 2003, Chest.

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Heber MacMahon, John K Field, Shaf Keshavjee, 2012, The Journal of thoracic and cardiovascular surgery.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

J. Jett, D. Naidich, P. Mazzone, 2015, Chest.

Pilot studies of the north central cancer treatment group (NCCTG) utilizing accelerated hyperfractionated thoracic radiation therapy (AHTRT) in unresectable stage IIIA/B non-small cell lung cancer (NSCLC)

E. Shaw, J. Jett, S. Nair, 1994 .

Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly

J. Jett, S. Mandrekar, J. Krook, 2005, Cancer.

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

J. Jett, S. Geyer, S. Schild, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.

J. Jett, R. Marks, J. Kugler, 2002, International journal of radiation oncology, biology, physics.

Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220.

V. Rusch, J. Jett, D. Gandara, 2014, The Annals of thoracic surgery.

Treatment toxicities in long-term survivors of limited small cell lung cancer.

E. Shaw, J. Jett, E. Creagan, 1988, Cancer investigation.

Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Peter B Bach, J. Jett, G. Silvestri, 2007, Chest.

PD-080 A pooled analysis of 11 NCCTG advanced stage non-small cell lung cancer (NSCLC) trials reveals the importance of baseline blood counts on clinical outcomes

J. Jett, S. Mandrekar, S. Hillman, 2005 .

A pooled analysis of 11 NCCTG advanced stage non-small cell lung cancer (NSCLC) trials reveals the importance of baseline blood counts on clinical outcomes

J. Jett, S. Mandrekar, S. Hillman, 2005 .

Lung cancer: Current concepts and prospects

J. Jett, D. Cortese, R. Fontana, 1983, CA: a cancer journal for clinicians.

Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total lung dose/volume histogram

J. Jett, F. Sciurba, J. Greenberger, 1995 .

The O utcome o f C ombined-Modalit y T herapy f or S tage I II Non-Small-Cell L ung C ancer i n t he E lderly

J. Jett, S. Geyer, S. Schild, 2003 .

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study.

J. Jett, S. Mandrekar, M. Aubry, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

242 Promising long term outcome of weekly paclitaxel and carboplatin with simultaneous thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC)

R. Day, J. Jett, J. Aisner, 1997 .

The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.

V. Lowe, J. Jett, M. Aubry, 2007, Chest.

Screening for lung cancer: The US studies

J. Jett, D. Midthun, 2013, Journal of surgical oncology.

The Intersection of Lung Cancer Screening, Radiomics, and Artificial Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer?

J. Jett, G. Silvestri, 2023, Journal of Clinical Oncology.

D7-07: A phase II NCCTG “Window of Opportunity Front-line” study of the mTOR Inhibitor, CCI-779 (Temsirolimus) given as a single agent in patients with advanced NSCLC

J. Jett, S. Mandrekar, R. Marks, 2007 .

Combined modality therapy in small cell lung cancer.

J. Jett, R. Arriagada, A. Gregor, 1994, Lung cancer.

Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population.

Rebecca M. Lindell, S. Swensen, V. Lowe, 2005, AJR. American journal of roentgenology.

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.

E. Shaw, J. Jett, E. Creagan, 1996, American journal of clinical oncology.

A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19.

J. Jett, M. Tsao, K. Ding, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.

J. Jett, D. Midthun, 2004, Chest.

Screening for Lung Cancer. Improving Outcomes with Better Patient Selection.

J. Jett, A. Vachani, 2016, American journal of respiratory and critical care medicine.

Advances in chemotherapy of non-small cell lung cancer.

J. Jett, A. Adjei, J. Molina, 2006, Chest.

Non-Hodgkin's lymphoma presenting as Pancoast's syndrome.

J. Jett, S. Arcasoy, M. Bajwa, 1997, Respiratory medicine.

A phase II NCCTG/CALGB trial of imatinib (STI571) in patients (pts) with c-kit-expressing relapsed small cell lung cancer (SCLC)

J. Jett, S. Mandrekar, M. Aubry, 2005 .

Change in smoking status after low-dose spiral chest CT screening for lung cancer: opportunity for smoking intervention

M. Clark, J. Jett, 2009, Thorax.

Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease

J. Jett, S. Schild, J. Niska, 2018, Clinical lung cancer.

Differing Response Rates and Survival Between Squamous and Non‐Squamous Non‐Small Cell Lung Cancer Comparison of CAP Versus MAP

J. Jett, E. Creagan, S. Frytak, 1986, American journal of clinical oncology.

Invasive and noninvasive advances in the staging of lung cancer.

J. Jett, F. Maldonado, 2014, Seminars in oncology.

Chapter 47 – Lung Tumors

J. Jett, D. Midthun, 2008 .

A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.

J. Jett, K. Halling, O. Rickman, 2006, Chest.

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium

J. Jett, H. Pass, W. Rom, 2015, Clinical Proteomics.

The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly.

J. Jett, S. Mandrekar, A. Adjei, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early Stage Lung Cancer—New Approaches to Evaluation and Treatment: Conference Summary Statement

C. Henschke, J. Jett, G. Scagliotti, 2005, Clinical Cancer Research.

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules

J. Jett, D. Weycker, J. Edelsberg, 2018, PloS one.

Lung cancer screening in 2008: A review and update

J. Jett, S. P. Nana-Sinkam, E. Brawner, 2008 .

Chemotherapy for malignant mesothelioma: CAMEO

J. Jett, R. Eagan, 1982, American journal of clinical oncology.

The Current Management of Thymic Tumors

J. Jett, J. Luketich, 1997 .

How to optimize staging in early non-small cell lung cancer.

J. Jett, 2002, Lung cancer.

P2.13-013 Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort

J. Jett, A. Murray, L. Peek, 2017 .

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

Elisabeth Brambilla, Edward F. Patz, Kari Chansky, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Changing of the Guard

J. Jett, 2013 .

Computed Tomography Screening and Lung Cancer Outcomes

C. Begg, S. Swensen, J. Jett, 2008 .

BLOOD REPOSITORY FOR THE VALIDATION OF LUNG CANCER BIOMARKERS LUNG CANCER BIOMARKERS GROUP

S. Hanash, D. Aberle, J. Jett, 2007 .

A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.

T. Fleming, J. Jett, J. Laurie, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Small Cell Lung Cancer Diagnosis and Management of Lung Cancer , 3 rd ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

J. Jett, S. Schild, G. Kalemkerian, 2013 .

The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

J. Crowley, V. Rusch, R. Rami-Porta, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancer screening results: easily misunderstood.

S. Swensen, J. Jett, T. Hartman, 2007, Mayo Clinic proceedings.

Age, gender, performance status and stage outperformed stage alone in predicting overall survival (OS) in patients with small cell lung cancer: A pooled analysis of 1,623 patients from the North Central Cancer Treatment Group

J. Jett, S. Mandrekar, N. Foster, 2007 .

Five-year Lung Cancer Screening Experience: CTAppearance,GrowthRate, Location,andHistologicFeaturesof

Rebecca M. Lindell, S. Swensen, J. Jett, 2007 .

O-73 High dose, twice-daily thoracic radiotherapy (TRT) with daily chemotherapy in limited stage small cell lung cancer

J. Jett, J. Sloan, S. Hillman, 2003 .

O-68 Long term results of a phase III trial comparing once a day radiotherapy (qd RT) or twice a day radiotherapy (bid RT) in limited stage small cell lung cancer (LSCLC)

J. Jett, S. Hillman, J. Krook, 2003 .

Spiral computed tomography screening for lung cancer is ready for prime time.

J. Jett, 2001, American journal of respiratory and critical care medicine.

Clinical Respiratory Medicine

J. Jett, R. Albert, S. Spiro, 2004 .

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

J. Austin, I. Petersen, V. Rusch, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Brief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study

J. Jett, S. Mandrekar, R. Marks, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic factors differ by tumor stage for small cell lung cancer

J. Jett, S. Mandrekar, R. Marks, 2009, Cancer.

Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations.

J. Jett, W. Pao, Y. Yatabe, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Road ahead to respiratory health: Experts chart future research directions

D. Hansell, J. Jett, J. Stradling, 2009, Respirology.

Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group.

T. Therneau, J. Jett, R. Goldberg, 1990, Journal of the National Cancer Institute.

Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis.

S. Swensen, J. Jett, D. Midthun, 2010, Chest.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small cell lung cancer: Results from an ECOG prospective randomized trial of postoperative adjuvant therapy (E3590, INT0015)

J. Jett, S. Adak, R. Livingston, 2000 .

Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2 Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.

J. Jett, P. Mazzone, N. Tanner, 2020, Chest.

The Analysis of Volatile Organic Compound Profiles in the Breath as a Biomarker of Lung Cancer

J. Jett, P. Mazzone, P. Rhodes, 2013 .

Screening for lung cancer: Who should be screened?

J. Jett, 2012, Archives of pathology & laboratory medicine.